LI
Insider
Lilly Endowment Inc
OtherLilly Endowment Inc (Other) filed 35 Form 4 reports as a reporting entity in the trailing twelve months (0 purchases, 35 sales, 1 filed past the two-business-day deadline), most often in Eli Lilly and Company (LLY). The largest single filing was $75.9B of LLY (178,295 sh across 4 lots, as filed), executed Nov 14 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
35
0 buys · 35 sells · 1 late
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$79.3B
shares × price, as filed
Last traded
May 6
Filed May 7
Median ADV $3.8B across their filed names
Open performance→Volume by month
Buys $0
Sells $82.0B
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
34 filings
Sector per market data · by filing · past 12 months
Most traded names
LLYRecent filings
LLYSALE
Eli Lilly and Company
View filing →
$15.8M15,828 sh across 2 lots
Exec May 6
Filed May 7 · 5:30 PM ET LLYSALE Eli Lilly and Company View filing → $322.4M
292,148 sh across 30 lots
Exec Jan 7
Filed Jan 8 · 5:30 PM ET LLYSALE Eli Lilly and Company View filing → $1.5M
1,390 sh × $1,085.01
Exec Jan 5
Filed Jan 6 · 5:30 PM ET LLYSALE Eli Lilly and Company View filing → $3.9M
3,593 sh × $1,085.04
Exec Dec 29 2025
Filed Dec 30 2025 · 5:30 PM ET LLYSALE Eli Lilly and Company View filing → $2.9M
2,629 sh × $1,085.17
Exec Dec 24 2025
Filed Dec 29 2025 · 5:30 PM ET LLYSALE Eli Lilly and Company View filing → $260K
240 sh × $1,085.04
Exec Dec 23 2025
Filed Dec 29 2025 · 5:30 PM ET † LLYSALE Eli Lilly and Company View filing → $161.1M
147,061 sh across 30 lots
Exec Nov 25 2025
Filed Nov 26 2025 · 5:30 PM ET LLYSALE Eli Lilly and Company View filing → $17.3M
15,632 sh across 3 lots
Exec Nov 25 2025
Filed Nov 26 2025 · 5:30 PM ET More filings →